X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AM | 2025-01-15 | AVIR | Berger Franklin M | Dir | P - Purchase | $3.26 | +25,000 | 476,897 | +6% | +$81,499 | |||||
| M | 2025-01-15 | AVIR | Berger Franklin M | Dir | P - Purchase | $3.26 | +25,000 | 476,897 | +6% | +$81,499 | |||||
2024-12-10 | AVIR | Berger Franklin M | Dir | S - Sale | $2.85 | -359,606 | 451,897 | -44% | -$1,023,475 | ||||||
| M | 2024-09-17 | AVIR | Sommadossi Jean-Pierre | Pres, CEO,, COB | S - Sale | $4.04 | -57,969 | 5,982,582 | -1% | -$234,155 | |||||
| D | 2024-06-20 | AVIR | Polsky Bruce | Dir | S - Sale+OE | $3.49 | -17,544 | 65,606 | -21% | -$61,144 | |||||
2024-06-05 | AVIR | Sommadossi Jean-Pierre | Pres, CEO,, COB | S - Sale | $4.00 | -1,006 | 6,040,551 | 0% | -$4,024 | ||||||
| D | 2024-02-01 | AVIR | Corcoran Andrea | See Remarks | S - Sale+OE | $3.84 | -15,843 | 670,208 | -2% | -$60,915 | |||||
| D | 2024-02-01 | AVIR | Sommadossi Jean-Pierre | Pres, CEO,, COB | S - Sale+OE | $3.85 | -56,910 | 6,041,557 | -1% | -$218,819 | |||||
| D | 2024-02-01 | AVIR | Horga Maria Arantxa | Chief Medical Officer | S - Sale+OE | $3.84 | -15,870 | 25,664 | -38% | -$60,963 | |||||
| D | 2024-02-01 | AVIR | Foster Wayne | EVP, Chief Accounting Officer | S - Sale+OE | $3.84 | -12,477 | 20,857 | -37% | -$47,904 | |||||
| D | 2024-02-01 | AVIR | Vavricka John | Chief Commercial Officer | S - Sale+OE | $3.84 | -11,819 | 104,023 | -10% | -$45,420 | |||||
| D | 2024-02-01 | AVIR | Hammond Janet Mj | Chief Development Officer | S - Sale+OE | $3.84 | -14,029 | 35,362 | -28% | -$53,913 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |